Artios Pharma

Artios Pharma

Artios Pharma

Artios is a leading independent DNA Damage Response (DDR) company focussed on developing firstinclass treatments for cancer.
Founded
2016
Raised
$119.3M
Follow us
Alexa global traffic share
Twitter followers
10 Aug 2018
£65,000,000
Venture capital (Series B)
£25,000,000
Undisclosed